title: How can we trick the immune system into overcoming the detrimental effects of oncolytic viral therapy to treat glioblastoma?
authors.forename: Walter H
authors.initials: WH
authors.lastname: Meisen
authors.forename: Balveen
authors.initials: B
authors.lastname: Kaur
mesh_terms: D001932:Brain Neoplasms / Q000276:immunology* / Q000628:therapy*; D005909:Glioblastoma / Q000276:immunology* / Q000628:therapy*; D006801:Humans; D050130:Oncolytic Virotherapy / Q000009:adverse effects*
references.citation: J Natl Cancer Inst. 2006 Mar 1;98(5):298-300
references.pmid: 16507823
references.citation: Hum Gene Ther. 1999 Nov 20;10(17):2869-78
references.pmid: 10584932
references.citation: Cancer Res. 2007 Oct 1;67(19):9398-406
references.pmid: 17909049
references.citation: Clin Cancer Res. 2012 Sep 15;18(18):4931-41
references.pmid: 22753591
references.citation: Cancer Invest. 2006 Aug-Sep;24(5):521-7
references.pmid: 16939962
references.citation: Nat Med. 2012 Dec;18(12):1827-34
references.pmid: 23178246
references.citation: Cytokine Growth Factor Rev. 2010 Apr-Jun;21(2-3):127-34
references.pmid: 20399700
references.citation: Gene Ther. 1998 Jan;5(1):121-30
references.pmid: 9536273
references.citation: Gene Ther. 2013 Mar;20(3):255-61
references.pmid: 22476202
references.citation: J Natl Cancer Inst. 2007 Dec 5;99(23):1768-81
references.pmid: 18042934
references.citation: Proc Natl Acad Sci U S A. 2000 Feb 29;97(5):2208-13
references.pmid: 10681459
references.citation: J Virol. 2000 May;74(10):4765-75
references.pmid: 10775615
references.citation: Mol Ther. 2008 Aug;16(8):1382-91
references.pmid: 18545226
references.citation: Clin Cancer Res. 2009 Jan 15;15(2):561-9
references.pmid: 19147761
references.citation: Mol Ther. 2012 Jan;20(1):37-45
references.pmid: 21915104
references.citation: Br J Nutr. 2002 May;87(5):393-403
references.pmid: 12010579
references.citation: Mol Ther. 2008 Jun;16(6):1041-7
references.pmid: 18388912
references.citation: Mol Ther. 2008 Sep;16(9):1546-55
references.pmid: 18648350
references.citation: Cancer Res. 2012 Mar 15;72(6):1353-62
references.pmid: 22282654